Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John J Acton

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Bioorganic & Medicinal Chemistry Letters|December 18, 2004
Benzoyl 2-methyl indoles as selective PPARgamma modulatorsJohn J Acton, Regina M Black, A Brian Jones, et al.
Bioorganic & Medicinal Chemistry Letters|May 3, 2005
Selective PPARgamma modulators with improved pharmacological profilesKun Liu, Regina M Black, John J Acton, et al.
Journal of Medicinal Chemistry|June 11, 2009
Discovery of (2R)-2-(3-{3-[(4-Methoxyphenyl)carbonyl]-2-methyl-6-(trifluoromethoxy)-1H-indol-1-yl}phenoxy)butanoic acid (MK-0533): a novel selective peroxisome proliferator-activated receptor gamma modulator for the treatment of type 2 diabetes mellitus with a reduced potential to increase plasma and extracellular fluid volumeJohn J Acton, Taro E Akiyama, Ching H Chang, et al.
Journal of Medicinal Chemistry|September 4, 2024
Discovery and Optimization of N-Heteroaryl Indazole LRRK2 InhibitorsKaitlyn M Logan, Will Kaplan, Vladimir Simov, et al.
Journal of Medicinal Chemistry|December 30, 2021
Structure-Guided Discovery of Aminoquinazolines as Brain-Penetrant and Selective LRRK2 InhibitorsMitchell H Keylor, Anmol Gulati, Solomon D Kattar, et al.
Journal of Medicinal Chemistry|December 8, 2022
Discovery and Optimization of Potent, Selective, and Brain-Penetrant 1-Heteroaryl-1<i>H</i>-Indazole LRRK2 Kinase Inhibitors for the Treatment of Parkinson's DiseaseDavid A Candito, Vladimir Simov, Anmol Gulati, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Bioorganic & Medicinal Chemistry Letters|December 18, 2004
Benzoyl 2-methyl indoles as selective PPARgamma modulatorsJohn J Acton, Regina M Black, A Brian Jones, et al.
Bioorganic & Medicinal Chemistry Letters|May 3, 2005
Selective PPARgamma modulators with improved pharmacological profilesKun Liu, Regina M Black, John J Acton, et al.
Journal of Medicinal Chemistry|June 11, 2009
Discovery of (2R)-2-(3-{3-[(4-Methoxyphenyl)carbonyl]-2-methyl-6-(trifluoromethoxy)-1H-indol-1-yl}phenoxy)butanoic acid (MK-0533): a novel selective peroxisome proliferator-activated receptor gamma modulator for the treatment of type 2 diabetes mellitus with a reduced potential to increase plasma and extracellular fluid volumeJohn J Acton, Taro E Akiyama, Ching H Chang, et al.
Journal of Medicinal Chemistry|September 4, 2024
Discovery and Optimization of N-Heteroaryl Indazole LRRK2 InhibitorsKaitlyn M Logan, Will Kaplan, Vladimir Simov, et al.
Journal of Medicinal Chemistry|December 30, 2021
Structure-Guided Discovery of Aminoquinazolines as Brain-Penetrant and Selective LRRK2 InhibitorsMitchell H Keylor, Anmol Gulati, Solomon D Kattar, et al.
Journal of Medicinal Chemistry|December 8, 2022
Discovery and Optimization of Potent, Selective, and Brain-Penetrant 1-Heteroaryl-1<i>H</i>-Indazole LRRK2 Kinase Inhibitors for the Treatment of Parkinson's DiseaseDavid A Candito, Vladimir Simov, Anmol Gulati, et al.
Pageof 1